Emtricitabine/Tenofovir disoproxil fumarate
Emtricitabine/Tenofovir disoproxil fumarate is a pharmaceutical drug with 24 clinical trials. Historical success rate of 100.0%.
Success Metrics
Based on 24 completed trials
Phase Distribution
Phase Distribution
4
Early Stage
2
Mid Stage
13
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
100.0%
24 of 24 finished
0.0%
0 ended early
0
trials recruiting
24
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Post-Exposure Prophylaxis in Health Care Workers
Bone Mineral Density Substudy - An Ancillary Study to MTN-003
Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants
Preventing Sexual Transmission of HIV With Anti-HIV Drugs
Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy
Clinical Trials (24)
Post-Exposure Prophylaxis in Health Care Workers
Bone Mineral Density Substudy - An Ancillary Study to MTN-003
Evaluating the Efficacy and Safety of Dolutegravir-Containing Versus Efavirenz-Containing Antiretroviral Therapy Regimens in HIV-1-Infected Pregnant Women and Their Infants
Preventing Sexual Transmission of HIV With Anti-HIV Drugs
Comparison of Three Anti-HIV Regimens to Prevent Nevirapine Resistance in Women Who Take Nevirapine During Pregnancy
Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their Infants
Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
Safety and Effectiveness of TFV 1% Gel, TDF Tablets, and FTC/TDF Tablets in Preventing HIV in Women
Study of Options for Second-Line Effective Combination Therapy (SELECT)
PrEP Demonstration Project (PRELUDE Study)
Comparing PI-Based to a nNRTI-based ART for Clearance of Plasmodium Falciparum Parasitemia in HIV-Infected
A5288/MULTI-OCTAVE: Management Using Latest Technologies to Optimize Combination Therapy After Viral Failure
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
Determining the Effects of Observed and Self-Administered Drug Regimens in HIV Infected Adults
NNRTI vs PI Regimens for HIV Infected Women After They Have Taken Nevirapine to Prevent Mother-To-Child HIV Transmission
HIV Treatment Reinitiation in Women Who Received Anti-HIV Drugs to Prevent Mother-to-Child Transmission of HIV
Prospective Evaluation of Anti-retroviral Combinations for Treatment Naive, HIV Infected Persons in Resource-limited Settings
A Key Link for Transmission Prevention
Safety and Effectiveness of Lopinavir/Ritonavir in Individuals Who Have Failed Prior HIV Therapy
Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 24